Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis

Depressive symptoms are highly prevalent in patients with chronic atrophic gastritis (CAG) but are frequently under-detected due to stigma and reliance on subjective questionnaires. This multicenter, cross-sectional observational study aims to validate a novel clinical triage workflow. It repurposes routine vascular assessments (specifically dorsalis pedis artery ultrasound and arterial stiffness metrics) as objective "biological entry points" to facilitate mental health referrals. The study will enroll approximately 450-520 adults with histologically confirmed CAG across four clinical centers in China. The primary objective is to determine the diagnostic accuracy of these vascular biomarkers for identifying patients with moderate-to-severe depressive symptoms (PHQ-9 score \>= 10). Secondary objectives include evaluating the implementation feasibility (e.g., referral uptake, screening completion rate) of this integrated care model in routine gastroenterology practice.

Participants needed: 520
Trial details
Age: 20-60Biological sex: AllType: ObservationalSponsor: China Academy of Chinese Medical SciencesUpdated: Jan 6, 2026Locations: 4
Eligibility criteria

Age between 20 and 60 years, regardless of sex. [+3]

History of major psychiatric disorders (e.g., schizophrenia, bipolar disorder) o... [+6]

Status: Not yet recruiting

A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills

To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the drug.

Participants needed: 1,000
Trial details
Age: 45-55Biological sex: FemaleType: ObservationalSponsor: China Academy of Chinese Medical SciencesUpdated: Mar 13, 2025
Eligibility criteria

Age: 45-55 years old [+2]

Individuals allergic to any components of the drug or excipients; [+9]